Page last updated: 2024-10-30

metformin and Exanthema

metformin has been researched along with Exanthema in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Exanthema: Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mumoli, L1
Gambardella, A1
Labate, A1
Succurro, E1
De Sarro, G1
Arturi, F1
Gallelli, L1
Tran, HA1
Chua, Y1
Petrovsky, N1

Other Studies

2 other studies available for metformin and Exanthema

ArticleYear
Rosacea-like facial rash related to metformin administration in a young woman.
    BMC pharmacology & toxicology, 2014, Feb-08, Volume: 15

    Topics: Adult; Drug Eruptions; Exanthema; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin

2014
Test and teach. Number Fifty-three. Diagnosis: Diabetes-related dyslipidaemia.
    Pathology, 2004, Volume: 36, Issue:6

    Topics: Adult; Diabetes Mellitus, Type 2; Exanthema; Female; Humans; Hyperlipidemias; Insulin; Metformin; Tr

2004